PMID: 9544975Apr 17, 1998Paper

Plasma fibronectin during myocardial ischemia-reperfusion: effects of magnesium, diltiazem, and a novel Mac-1 inhibitor

American Journal of Hematology
V L SerebruanyP A Gurbel

Abstract

The important role of fibronectin (Fn) has been recognized in patients with ischemic heart disease. However, serial changes of Fn during both brief and prolonged ischemia-reperfusion are poorly known. Plasma Fn was measured during acute myocardial infarction (AMI) and myocardial stunning (MS), and in the absence of myocardial injury. The effects of magnesium (Mg), diltiazem, and a Mac-1 inhibitor on the level of Fn were elucidated. Forty-nine swine underwent prolonged (50 min) or brief (8 min) coronary artery occlusion followed by reperfusion, while six control animals were free of ischemia. During the AMI experiments, plasma Fn underwent a significant progressive increase. Mg or diltiazem similarly affects the plasma Fn, reducing its release during the entire reperfusion period, and did not influence the plasma Fn in the absence of myocardial injury. Contrarily, Mac-1 inhibition resulted in the Fn elevation in controls, and during the occlusion phase, with no significant effect during reperfusion. There were no changes in the plasma Fn during MS, while inhibition of Mac-1 was associated with the significant increase of Fn during ischemia-reperfusion. Ability of Mg, diltiazem, and leumedins to modulate plasma Fn level may have ...Continue Reading

References

Dec 1, 1992·Circulation·R Bolli
Oct 1, 1992·European Journal of Haematology·E SøftelandH Holmsen
May 22, 1990·The American Journal of Cardiology·B R Lucchesi
Sep 1, 1990·Circulation·R Bolli
Jun 1, 1989·Clinical Cardiology·T O Cheng
Nov 1, 1985·The Journal of Clinical Investigation·E Braunwald, R A Kloner
Dec 1, 1982·Circulation·E Braunwald, R A Kloner
Nov 15, 1993·Biochemical and Biophysical Research Communications·P J HartfieldR D Camp
Oct 1, 1994·Journal of Cardiovascular Pharmacology·D AtarW R Herzog
Nov 1, 1995·Circulation·W R HerzogV L Serebruany
May 1, 1993·The Journal of Surgical Research·P W ChoD E Cameron
Aug 31, 1993·Biochemical and Biophysical Research Communications·P A Norton, R O Hynes
Jan 1, 1995·Journal of Thrombosis and Thrombolysis·W R HerzogV L Serebruany
Sep 1, 1991·Trends in Cardiovascular Medicine·D J Hearse, R Bolli

❮ Previous
Next ❯

Citations

Mar 17, 2005·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Peter KossmehlDaniela Grimm

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.